Brains Bioceutical Corp’s Solid THC Paves the Way for Revolutionary Drug Development for the pharmaceutical industry

  • by

Brains Bioceutical Corp (“Brains Bio” or the “Company”), Brains Bio, a pioneer in the cannabinoid-based pharmaceutical industry, is proud to announce a significant breakthrough in the journey to a world’s first solid Tetrahydrocannabinol (THC) as an Active Pharmaceutical Ingredient (API). This milestone reflects the company’s commitment to innovation and its position at the forefront of the cannabinoid pharmaceutical industry.